Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

CUSIP: 00461U105

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, $0.00001 par value
Shares outstanding
119,747,899
Total 13F shares
71,610,627
Share change
+5,663,213
Total reported value
$579,302,266
Put/Call ratio
68%
Price per share
$8.09
Number of holders
148
Value change
+$19,605,105
Number of buys
82
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) as of Q1 2023

As of 31 Mar 2023, Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) was held by 148 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,610,627 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., Rock Springs Capital Management LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, BRAIDWELL LP, VANGUARD GROUP INC, CITADEL ADVISORS LLC, and Foresite Capital Management IV, LLC. This page lists 148 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.